CLINICAL_TRIALS
trial_result
· 2018-05-16
Clinical Trial Update: An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738) [Phase 2, Phase 3]
Summary
Clinical trial update for verubecestat (MK-8931) in mild to moderate Alzheimer's disease showing termination with posted results in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Alzheimer's Disease | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2018-05-16